ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,959,000 | +17.7% | 179,705 | +17.9% | 0.99% | +13.6% |
| Q1 2021 | $6,763,000 | +7.6% | 152,418 | +33.0% | 0.87% | -0.1% |
| Q4 2020 | $6,283,000 | +231.0% | 114,568 | +38.0% | 0.87% | +147.6% |
| Q3 2020 | $1,898,000 | +249.5% | 83,008 | +113.3% | 0.35% | +96.1% |
| Q1 2020 | $543,000 | +95.3% | 38,910 | +218.4% | 0.18% | +141.9% |
| Q4 2019 | $278,000 | – | 12,220 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |